Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Sorbidin TM
Listen to the Pronunciation:
Active ingredients: isosorbide dinitrate
What it is used for
Treatment of angina pectoris (classic effort associated angina, chronic stable angina, vasospastic angina, variant angina, unstable angina and angina decubitus) and myocardial ischaemia due to ischaemic heart disease. The tablets are not intended to abort the acute anginal episode, but are useful in the prophylactic treatment of angina pectoris and myocardial ischaemic heart disease. An aid in the management of left ventricular failure, either alone or as part of the syndrome of congestive heart failure.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
8mm normal convex white tablet marked "IS/10" on one side, " " on the reverse.
Images are the copyright of Medicines Information Pty Ltd
We are currently experiencing issues with Medicines Information data. Images displayed may not be current, please refer to the CMI.
Do I need a prescription?
This medicine is available from a pharmacy without prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient isosorbide dinitrate
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.